Mercaptobenzamides: A Stepping-stone For Developing Next-Generation Anti-HIV Drugs Targeting Nucleocapsid Protein 7 (NCp7)
Share This:
                           

About The Author

Mrinmoy is a senior scientist at Abzena and is experienced in small molecule drug discovery, peptides and peptide nucleic acids (PNAs), antibody drug conjugates (ADCs), and total syntheses of natural products and synthetic methodology.

                       

Mercaptobenzamides: A Stepping-stone For Developing Next-Generation Anti-HIV Drugs Targeting Nucleocapsid Protein 7 (NCp7)

CD4 T lymphocytes are T-helper cells that harmonize the immune system to avert pathogenic infection. They do so by recruitment and activation of other immune cells, such as B-cells, macrophages, neutrophils and basophils. Weakening and damaging of the immune system by the impediment of this helper T-cell function is the focal cause of disease progression through HIV (Human Immunodeficiency Virus) infection. AIDS (Acquired Immunodeficiency Syndrome) is the advanced stage of the disease associated with vulnerability towards opportunistic infections and/or development...

Read more